158
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients

ORCID Icon, , , , , & show all
Pages 467-478 | Published online: 24 Nov 2020

References

  • Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
  • Johns Hopkins: Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [consulted 2020 May 22]. Available from: https://coronavirus.jhu.edu/map.html.
  • National Center for Epidemiology. Institute of health Carlos III (ISCIII) [consulted 2020 Jun 24]. Available from: https://cnecovid.isciii.es/covid19.
  • Brake S, Barnsley K, Lu W, et al. Smoking upregulates angiotensin-Converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS- CoV-2 (Covid-19). JMC. 2020;9:841.
  • Ferrario C, Jessup J, Chappell M, et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation. 2005;111(20):2605–2610. doi:10.1161/CIRCULATIONAHA.104.510461
  • Mackman N, Antoniak S, Wolberg AS, et al. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arteriosclerosis Thrombosis Vasc Biol. 2020;40(9):2033–2044. doi:10.1161/ATVBAHA.120.314514
  • Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
  • Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad. Clin Rheumatol. 2020;39(9):2529–2543. doi:10.1007/s10067-020-05275-1
  • Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1–13. doi:10.1016/j.trsl.2020.04.007
  • Connors JM, Levy JH. Thromboinflammation and the Hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561. doi:10.1111/jth.14849
  • Hu Y, Sun J, Dai Z, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020;127:104371. doi:10.1016/j.jcv.2020.104371
  • Verma V, Vishwakarma RK, Verma A, Nath DC, Khan HTA, Navaneetham K. Time-to-Death Approach in Revealing Chronicity and Severity of COVID-19 Across the World. PLoS One. 2020;15(5):e0233074. doi:10.1371/journal.pone.0233074
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;13:3200994.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Jain U. Effect of COVID-19 on the Organs. Cureus. 2020;12:e9540.
  • Galván Casas C, Catalá A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID −19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77. doi:10.1111/bjd.19163
  • Bouaziz JD, Duong T, Jachiet M, et al. Vascular skin symptoms in COVID-19: a french observational study. J Eur Acad Dermatol Venereol. 2020;27.
  • Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, et al. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol. 2020;83(1):e61–3. doi:10.1016/j.jaad.2020.04.093
  • Piccolo V, Neri I, Filippeschi C, et al. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol. 2020;34(7). doi:10.1111/jdv.16526
  • Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020;pii: S0735-1097(20)35008–7.
  • Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575
  • Zhang Y, Cao W, Xiao M, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhinghua Xue Xue Za Zhi. 2020;41:E006.
  • Perini P, Nabulsi B, Massoni CB, et al. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. 2020;395(10236):1546. doi:10.1016/S0140-6736(20)31051-5
  • Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A, et al. COVID-19-Related Aortic Thrombosis: A Report of Four Cases. Ann Vasc Surg. 2020;67:10–13. doi:10.1016/j.avsg.2020.05.031
  • Chiappelli F, Bakhordarian A, Thames AD, et al. Ebola: translational science considerations. J Transl Med. 2015;13:11.
  • Khan ID, Khan SA, Asima B, Hussaini SB, Zakiuddin M, Faisal FA. Morbidity and mortality amongst Indian Hajj pilgrims: A 3-year experience of Indian Hajj medical mission in mass-gathering medicine. J Infect Public Health. 2018;11(2):165–170. doi:10.1016/j.jiph.2017.06.004
  • Lancet T, The Lancet. COVID-19. COVID-19: protecting health-care workers. Lancet. 2020;395(10228):922. doi:10.1016/S0140-6736(20)30644-9
  • Mahli A, Coskun D, Cosarcan K. Peripheral sympathetic block with therapeutic local anesthesia for the management of upper limb digital ischemia. Hippokratia. 2018;22:141–143.
  • Fakoor F, Fazeli B. Visceral bed involvement in thromboangiitis obliterans: a systematic review. Vasc Health Risk Manag. 2019;15:317–353. doi:10.2147/VHRM.S182450
  • Fazeli B, Farzadnia M, Taheri TH. Vaso-nervorumitis: responsible for pain in Buerger’s disease? Int Med Case Rep. 2019;12:119–123. doi:10.2147/IMCRJ.S197862
  • Batlle D, Soler MJ, Sparks MA, et al. Acute Kidney Injury in COVID-19: emerging Evidence of a Distinct Pathophysiology. J Am Soc Nephrol. 2020;31(7):1380–1383. doi:10.1681/ASN.2020040419
  • White LE, Hassoun HT. Inflammatory mechanisms of Organ Crosstalk during Ischemic Acute Kidney Injury. Int J Nephrology. 2012;2012:505197. doi:10.4061/2012/505197
  • Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73(1):89–99. doi:10.1016/j.jacc.2018.09.086
  • Ghimire A, Bisset ES, Howlett SE. Ischemia and reperfusion injury following cardioplegic arrest is attenuated by age and testosterone deficiency in male but not female mice. Biol Sex Differences. 2019;10(1):42. doi:10.1186/s13293-019-0256-4
  • Mester A, Magyar Z, Molnar A, et al. Age- and gender-related hemorheological alterations in intestinal ischemia-reperfusion in the rat. J Surg Res. 2018;225:68–75. doi:10.1016/j.jss.2017.12.043
  • Bellis A, Sorriento D, Fiordelisi A, et al. Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells. Int J Mol Sci. 2020;21(8):2965. doi:10.3390/ijms21082965
  • Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–1520. doi:10.1016/S0140-6736(20)30920-X
  • Devgire V, Hughes M. Raynaud’s phenomenon. Br J Hospital Med. 2019;80(11):658–664. doi:10.12968/hmed.2019.80.11.658
  • Brencher L, Verhaegh R, Kirsch M. Attenuation of intestinal ischemia-reperfusion-injury by β-alanine: a potentially glycine-receptor mediated effect. J Surg Res. 2017;211:233–241. doi:10.1016/j.jss.2016.12.023
  • Kluger N, Scrivener JN. The use of Google trends for acral symptoms during COVID-19 outbreak in France. J Eur Acad Dermatol Venereol. 2020;34(8):e358–60. doi:10.1111/jdv.16572
  • Middeldorp S, Coppens M, van Haaps T, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002. doi:10.1111/jth.14888
  • Boag SE, Andreano E, Spyridopoulos I. Lymphocyte Communication in Myocardial Ischemia/Reperfusion Injury. Antioxid Redox Signal. 2017;26(12):660–675. doi:10.1089/ars.2016.6940
  • Rello J, Storti E, Belliato M, Serrano R. Clinical Phenotypes of SARS-CoV-2: implications for Clinicians and Researchers. Eur Resp J. 2020;55(5):2001028. doi:10.1183/13993003.01028-2020
  • Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo LL. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost. 2020;120(06):949–956. doi:10.1055/s-0040-1710317
  • Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–1742. doi:10.1111/jth.14850
  • Yang P, Du Y, Zeng H, Xing H, Tian C, Zou X. Comparison of inflammatory markers between the sevoflurane and isoflurane anesthesia in a rat model of liver ischemia/reperfusion injury. Transplant Proc. 2019;51(6):2071–2075. doi:10.1016/j.transproceed.2019.04.022
  • Chen X, Wang Y, Xiao Z-Y, Hou D-N, Li D-B, Zhang X-P. Effect of propofol on myocardial ischemia/reperfusion injury in rats through JAK/STAT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:6330–6338.
  • Jacquemin M, NeyrincK A, Hermanns MI, et al. FVIII production by human lung microvascular endothelial cells. Blood. 2006;108(2):515–517. doi:10.1182/blood-2005-11-4571